Cargando…
Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
Cannabis has been considered as a therapeutic strategy to control intractable epilepsy. Several cannabis components, especially cannabidiol (CBD), induce antiseizure effects. However, additional information is necessary to identify the types of epilepsies that can be controlled by these components a...
Autores principales: | Rocha, Luisa, Frías‐Soria, Christian Lizette, Ortiz, José G., Auzmendi, Jerónimo, Lazarowski, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049809/ https://www.ncbi.nlm.nih.gov/pubmed/32140642 http://dx.doi.org/10.1002/epi4.12376 |
Ejemplares similares
-
Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
por: Fonseca‐Barriendos, Daniel, et al.
Publicado: (2021) -
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021) -
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
por: Gómez, Claudia Taborda, et al.
Publicado: (2021) -
Introduction to the special issue “Redesigning the hypotheses for drug‐resistant epilepsy”
por: Rocha, Luisa
Publicado: (2022) -
Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation
por: Campos‐Bedolla, Patricia, et al.
Publicado: (2022)